Charles Schwab’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $371K | Buy |
261,298
+228,219
| +690% | +$324K | ﹤0.01% | 3247 |
|
|
2025
Q1 | $50.6K | Hold |
33,079
| – | – | ﹤0.01% | 3401 |
|
|
2024
Q4 | $82K | Buy |
+33,079
| New | +$82K | ﹤0.01% | 3412 |
|
|
2024
Q3 | – | Sell |
-260,706
| Closed | -$287K | – | 3502 |
|
|
2024
Q2 | $287K | Sell |
260,706
-158,628
| -38% | -$174K | ﹤0.01% | 3376 |
|
|
2024
Q1 | $520K | Sell |
419,334
-16,996
| -4% | -$21.1K | ﹤0.01% | 3016 |
|
|
2023
Q4 | $458K | Sell |
436,330
-26,904
| -6% | -$28.2K | ﹤0.01% | 3103 |
|
|
2023
Q3 | $3.17M | Buy |
463,234
+18,973
| +4% | +$130K | ﹤0.01% | 2441 |
|
|
2023
Q2 | $4.61M | Buy |
444,261
+34,041
| +8% | +$353K | ﹤0.01% | 2265 |
|
|
2023
Q1 | $3.32M | Sell |
410,220
-1,913
| -0.5% | -$15.5K | ﹤0.01% | 2373 |
|
|
2022
Q4 | $6.49M | Buy |
412,133
+9,579
| +2% | +$151K | ﹤0.01% | 2072 |
|
|
2022
Q3 | $6.34M | Buy |
402,554
+248,235
| +161% | +$3.91M | ﹤0.01% | 2096 |
|
|
2022
Q2 | $2.16M | Buy |
154,319
+21,251
| +16% | +$297K | ﹤0.01% | 2549 |
|
|
2022
Q1 | $2.3M | Buy |
133,068
+4,155
| +3% | +$71.7K | ﹤0.01% | 2597 |
|
|
2021
Q4 | $1.88M | Buy |
128,913
+1,997
| +2% | +$29K | ﹤0.01% | 2721 |
|
|
2021
Q3 | $2.29M | Buy |
126,916
+19,078
| +18% | +$343K | ﹤0.01% | 2667 |
|
|
2021
Q2 | $1.89M | Buy |
107,838
+92,049
| +583% | +$1.62M | ﹤0.01% | 2734 |
|
|
2021
Q1 | $398K | Sell |
15,789
-4,716
| -23% | -$119K | ﹤0.01% | 3154 |
|
|
2020
Q4 | $133K | Hold |
20,505
| – | – | ﹤0.01% | 3296 |
|
|
2020
Q3 | $53K | Hold |
20,505
| – | – | ﹤0.01% | 3279 |
|
|
2020
Q2 | $34K | Sell |
20,505
-64,197
| -76% | -$106K | ﹤0.01% | 3274 |
|
|
2020
Q1 | $89K | Hold |
84,702
| – | – | ﹤0.01% | 3116 |
|
|
2019
Q4 | $161K | Hold |
84,702
| – | – | ﹤0.01% | 3060 |
|
|
2019
Q3 | $92K | Sell |
84,702
-121,887
| -59% | -$132K | ﹤0.01% | 3096 |
|
|
2019
Q2 | $453K | Buy |
206,589
+32,759
| +19% | +$71.8K | ﹤0.01% | 2854 |
|
|
2019
Q1 | $1.04M | Sell |
173,830
-26,103
| -13% | -$156K | ﹤0.01% | 2537 |
|
|
2018
Q4 | $1.48M | Buy |
199,933
+65,874
| +49% | +$487K | ﹤0.01% | 2420 |
|
|
2018
Q3 | $1.95M | Buy |
134,059
+11,916
| +10% | +$173K | ﹤0.01% | 2430 |
|
|
2018
Q2 | $2.44M | Sell |
122,143
-3,426
| -3% | -$68.4K | ﹤0.01% | 2312 |
|
|
2018
Q1 | $2.2M | Buy |
125,569
+3,802
| +3% | +$66.6K | ﹤0.01% | 2298 |
|
|
2017
Q4 | $3M | Buy |
121,767
+29,260
| +32% | +$722K | ﹤0.01% | 2153 |
|
|
2017
Q3 | $2.39M | Buy |
92,507
+30,742
| +50% | +$794K | ﹤0.01% | 2224 |
|
|
2017
Q2 | $1.68M | Buy |
61,765
+17,804
| +40% | +$483K | ﹤0.01% | 2280 |
|
|
2017
Q1 | $1.31M | Buy |
43,961
+2,736
| +7% | +$81.6K | ﹤0.01% | 2339 |
|
|
2016
Q4 | $1.12M | Buy |
41,225
+16,694
| +68% | +$453K | ﹤0.01% | 2391 |
|
|
2016
Q3 | $629K | Buy |
24,531
+816
| +3% | +$20.9K | ﹤0.01% | 2539 |
|
|
2016
Q2 | $439K | Buy |
23,715
+6,852
| +41% | +$127K | ﹤0.01% | 2634 |
|
|
2016
Q1 | $320K | Buy |
16,863
+306
| +2% | +$5.81K | ﹤0.01% | 2743 |
|
|
2015
Q4 | $447K | Buy |
+16,557
| New | +$447K | ﹤0.01% | 2692 |
|